Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
new york blog main
3
×
biotech
deals
life sciences
new york top stories
10x genomics
advance medical
american well
astellas pharma
becton dickinson
best doctors
boehringer ingelheim
boston blog main
cancer
cancer diagnostics
carlos nueno
clinical trials
diagnostic device
digital health
doctor on demand
eli lilly
empagliflozin
europe
europe blog main
europe top stories
expertise on demand
fda
healthcare
healthiestyou
healthtap
healthtech
idiopathic pulmonary fibrosis (ipf)
indiana blog main
indiana top stories
lung cancer
lymphoma
marc subirats
medical device
merck
What
expand
3
×
deal
reach
acquisition
add
adding
advance
aims
approval
based
bid
boehringer
borders
bought
buys
cash
company
decisions
diabetes
diagnostic
diagnostics
drug
eli
fallen
fda
fellow
fold
following
help
ingelheim
intended
lilly
make
marketed
medical
medicine’s
million
monday
nanostring
ny
Language
unset
Current search:
expand
×
" new york blog main "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Teladoc Buys Advance Medical for $352M to Expand Telehealth Services